The CEO of a B.C. biotechnology company says the treatment his firm has developed for COVID-19 is sitting on shelves while people continue to die, despite it being approved for use by Health Canada in the fall.
via CBC | Top Stories News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment